Arquivos do dia: Outubro 4, 2022
Recomendações AAP | Prevenção de mortes e lesões pediátricas relacionadas a quadriciclos.
4 Out, 2022 | 12:42hRelatório técnico: A Comprehensive Report on All-Terrain Vehicles and Youth: Continuing Challenges for Injury Prevention – Pediatrics
Comentários:
ATVs Are Not Safe for Children: AAP Policy Explained – Health Children
AAP Calls for Prevention of Pediatric ATV-Linked Deaths, Injuries – HealthDay
Relatório clínico AAP | Controle e tratamento de piolhos em crianças e adolescentes.
4 Out, 2022 | 12:41hComunicado de imprensa: American Academy of Pediatrics Updates Report on Controlling and Treating Head Lice in Children, Adolescents – American Academy of Pediatrics
Relatório clínico AAP | Avaliação de distúrbios de sangramento na suspeita de abuso infantil.
4 Out, 2022 | 12:40hEvaluation for Bleeding Disorders in Suspected Child Abuse – Pediatrics’
Relatório técnico: Evaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding – American Academy of Pediatrics
Comentário: AAP guidance helps distinguish bleeding disorders from abuse – MDedge
Estudo de coorte | Diabetes diagnosticado em adultos mais jovens está associado com morbidade aumentada em comparação ao diagnóstico feito em adultos mais velhos.
4 Out, 2022 | 12:39h
Recomendações de consenso | Atividades prioritárias para abordar a lesão renal aguda em crianças.
4 Out, 2022 | 12:37hComentário convidado: Highlights of Consensus-Based Recommendations for Acute Kidney Injury in Children – JAMA Network Open
Comentário no Twitter
Pediatric ADQI consensus statement describes the current state and future research, educational, & advocacy work to improve awareness of acute kidney injury in children and young adults, advance diagnostics, and move the needle for management. #OAResearch https://t.co/Qph7tSqicv
— JAMA Network Open (@JAMANetworkOpen) September 30, 2022
M-A de estudos randomizados | Colchicina e riscos de doença cardíaca coronariana.
4 Out, 2022 | 12:36hConteúdos relacionados:
Expert Analysis | Colchicine in acute coronary syndrome: when to commence?
Review: Colchicine and the heart.
M-A: Colchicine administration for percutaneous coronary intervention
M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease
Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease
Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease
#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome
Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome
Diretriz | Tratamento cirúrgico de abdome agudo após cirurgia bariátrica no ambiente de emergência.
4 Out, 2022 | 12:35hConteúdo relacionado: AGA clinical practice update on evaluation and management of early complications after bariatric/metabolic surgery.
Seguimento de longo prazo de um estudo randomizado | Monoterapia com inibidor de P2Y12 vs. terapia antiplaquetária dupla (dual antiplatelet therapy – DAPT) após intervenção coronariana percutânea.
4 Out, 2022 | 12:34hLong-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial – JAMA Cardiology (link para o resumo – $ para o texto completo)
Estudo original: Randomized Trials: Shorter Duration of Dual Antiplatelet Therapy May be an Option for Patients Undergoing Percutaneous Coronary Intervention
Comentário no Twitter
In #RCT follow-up, P2Y12 inhibitor monotherapy after 3 months of DAPT found to be comparable with prolonged DAPT for preventing ischemic events. P2Y12 inhibitor monotherapy resulted in significantly lower rate of major bleeding for up to 3 yrs. https://t.co/pBv9X87lEg #Research pic.twitter.com/42Y28hPPT2
— JAMA Cardiology (@JAMACardio) September 30, 2022
Estudo randomizado | Intervenção comportamental entregue via mensagens de texto não reduziu as reinfecções por doenças sexualmente transmitidas em jovens.
4 Out, 2022 | 12:32hComunicado de imprensa: Texting young people about safe sex does not reduce STI reinfection – BMJ Newsroom
Comentário no Twitter
New research: Sending regular texts to young people who have recently had a sexually transmitted infection (#STI) to encourage #safesex does not reduce rates of chlamydia and gonorrhoea reinfection, finds a trial published by @bmj_latest today.https://t.co/OgQqPAsbS7 pic.twitter.com/0QTLqPuzDX
— BMJ (@bmj_company) September 29, 2022
Breve revisão | Estratégia de sedação ótima para pacientes críticos.
4 Out, 2022 | 12:31h